Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Xinjiekou Department Store Offers $966 Million for China Cord Blood

publication date: Aug 6, 2015
Nanjing Xinjiekou Department Store Co. made an unsolicited offer of "not less than" $966 million to buy China Cord Blood Corp., a cord blood banking and stem cell processing company. In April, Golden Meditech, China Cord Blood's major owner, made a $771 million offer to take the company private. China Cord Blood has $394 million in cash and annual revenues of about $102 million. If re-listed in Hong Kong or on a China exchange, China Cord Blood could be worth $5 billion. More details.....

Stock Symbols: (NYSE: CO) (HK: 801)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital